Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Pittsburgh › NPI 1851651228
Physician

Tate, Patrick

Tate, Patrick was paid $1.26M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.

33Billing provider infoTATE, PATRICK
PITTSBURGH, PA 15227
33aNPI1851651228assigned 05/20/2012
33bProvider typePediatrics Physician
28Total paid$1.26M
24GClaims32,747
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Pennsylvania

Rank by total paid#82 of 1,257
Median peer was paid$45K
This provider vs. median28×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018249$20K
2019128$8K
2020312$19K
20215,563$230K
20227,444$292K
20239,540$357K
2024incomplete9,511$331K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 39% 6,196 5,857 $494K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14% 3,350 3,232 $172K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 11% 1,631 1,630 $134K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 8.5% 1,291 1,289 $107K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 8.3% 1,216 1,202 $104K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4.5% 625 624 $57K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 3.9% 417 388 $49K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.2% 726 708 $27K
99051 1.9% 874 867 $24K
87428 1.7% 717 707 $21K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.6% 1,315 1,289 $20K
99188 1.2% 766 763 $15K
37 more codes
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.1% 1,104 $14K
90686 <1% 984 $4K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 69 $2K
90670 <1% 596 $2K
90648 <1% 874 $2K
90633 <1% 411 $1K
90723 <1% 539 $1K
0071A <1% 19 $836.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 37 $714.10
0072A <1% 27 $660.00
92551 <1% 1,267 $572.06
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 793 $551.98
96127 <1% 987 $550.50
90680 <1% 405 $504.00
81002 <1% 136 $461.01
99177 <1% 866 $437.08
96160 <1% 962 $374.64
99173 <1% 287 $207.35
90651 <1% 312 $143.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 12 $122.00
85018 <1% 51 $20.22
G9920 Screening performed and negative 0% 864 $0.00
83655 0% 25 $0.00
90715 0% 28 $0.00
90710 0% 41 $0.00
90707 0% 14 $0.00
90661 0% 102 $0.00
90620 0% 27 $0.00
96161 0% 811 $0.00
90677 0% 300 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 358 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 12 $0.00
90619 0% 76 $0.00
90656 0% 134 $0.00
90716 0% 37 $0.00
90696 0% 42 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.